Nuacht

BioPharma Dive4 lá
Biotech is guessing how Vinay Prasad might change the FDA. His research, writing offer clues.
CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...
FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division
The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...
STAT6 lá
Vinay Prasad tapped to run FDA center that regulates vaccines, gene therapies
Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was ...
Science-Based Medicine3 láOpinion
Dr. Vinay Prasad is Now the Medical Establishment. It’s His Job to Run RCTs, and It’s Our Job to Call Him a Lying Piece of $#!& if He Fails.
From claiming COVID vaccines were perfect and would end the pandemic to treating rare, temporary vaccine side-effects, even ...
The Cardiology Advisor16 uair an chloig
Dr Vinay Prasad to Head FDA Vaccine, Biologics Division
The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.
FDA Names Vinay Prasad as New Head of Vaccines, Biologics
FDA Commissioner Marty Makary named Vinay Prasad, a hematologist oncologist and critic of the Covid-19 vaccine for children, ...
Fierce Pharma6 lá
FDA Commissioner Marty Makary taps Vinay Prasad to head up CBER
In the wake of the high-profile departure of Peter Marks, M.D., Ph.D., the FDA has a new leader for its Center for Biologics ...
BioSpace4 lá
Vinay Prasad’s FDA Appointment ‘Anything but Status Quo’
The UCSF professor and frequent YouTube poster has criticized COVID-19 vaccine mandates as well as the accelerated approval ...
Axios on MSN4 lá
Vinay Prasad believes that the FDA too often has acted as a rubber stamp for pharma, both big and small.
Biotech venture capital is risky business, inherently at the mercy of regulators and binary outcomes. Now it may face a new ...
Who Is Vinay Prasad? FDA Names Oncologist As New CBER Director
Vinay Prasad, an oncologist known for his past criticism of COVID-19 restrictions, has been appointed director of the US Food ...
BioPharma Dive6 lá
Prasad’s FDA appointment pressures cell and gene therapy stocks
A vocal opponent of his predecessor Peter Marks, Vinay Prasad will now lead the office tasked with reviewing some genetic ...
Medical Xpress6 lá
Dr. Vinay Prasad to head FDA vaccine, biologics division
The U.S. Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad, a professor at the University of California-San Francisco, to lead its Center for Biologics Evaluation and Research.